Anthony D. Sabatelli, Ph.D.


Anthony D. Sabatelli is an experienced patent practitioner and former biotech executive and research scientist, who provides insightful, practical, and business-oriented service to his clients. Although his primary focus is on biotechnology and the pharmaceutical industry, he has had broad experience across many areas of the chemical field including formulations and polymers. Dr. Sabatelli learned early on in his career that the successful patent practitioner must be an “Exclusivity Attorney” adept at understanding the complex interplay of patent, regulatory, and product life-cycle issues. He is versed in the Hatch-Waxman and regulatory laws relevant to pharmaceutical practice.

Having spent most of his career in-house, as both a research scientist and as a patent attorney, Dr. Sabatelli appreciates the needs and perspective of the inventors in the lab and the in-house attorneys who seek to protect those inventions. He listens to his clients to help them create robust, yet practical, portfolios, whether comprising a single patent case or several hundred patents. Above all, he enjoys sharing his passion for his work with his clients and colleagues. Dr. Sabatelli has a strong interest in and commitment to education. He is currently an Adjunct Professor of Chemistry at the University of New Haven and serves as Chairman of the Yale Graduate School Alumni Association.

  • Was one of ten speakers invited to testify before the US Patent & Trademark Office at the May 2014 public forum on the Guidance for patent eligible subject matter.
  • Designed, built, and managed a patent estate for a biotechnology company comprising a worldwide portfolio of several hundred patents.
  • Was an integral member of the senior management team of a biotechnology company which raised over $250 million in venture financing, and which in-licensed and progressed a novel antibiotic into Phase 3 clinical trials.
  • Led an interdepartmental company team that worked closely with its US Senator’s office on the passage of the 2012 Generating Antibiotic Incentives Now (GAIN) legislation, which provides important exclusivity and regulatory incentives for companies to develop new antibiotics for treating serious infections.
  • Built the underlying patent estate for a new chemical class of drugs for a research collaboration with a major pharmaceutical company in the area of infectious disease.
  • Had worldwide patent portfolio responsibility at a major pharmaceutical company for their billion-dollar bone biology franchise, where he implemented a comprehensive patent life cycle management strategy for the franchise’s flagship drug.
  • Successfully completed an over-seas assignment at a major consumer products company where he provided legal counsel for the Asia-Pacific product managers and trained the newly-hired patent staff.
  • As a product development manager at a major consumer products company led the reformulation of their sunscreen line, resulting in successful national expansion of the line.
  • Chaired, organized, and spoke at a highly successful full day career mentoring symposium at Yale University, "Where do I go from Yale?", an annual event designed to help graduate students explore career options and network with alumni.
  • Inventor on twelve issued U.S. patents.
Technology Areas

Anthony’s fields of technology include biotechnology, pharmaceuticals, small molecules, macromolecules, RNA and DNA, proteins, x-ray crystallography, consumer products, chemicals, ultraviolet absorbers, polymers, silicones, pharmaceutical and consumer products formulations, pharmaceutical and chemical manufacturing processes, and drug discovery research tools.

Selected Publications and Presentations

Sabatelli, A.D.  Connecticut High Tech Company Uses “Nature’s Fingerprint” to Add Value to Patent Portfolios, CURE (Connecticut United for Research Excellence) electronic Newsletter, October 8, 2013.

2011, 2012, and 2013, Legislative Day Fly-In Biotechnology Industry Organization (presentations to Connecticut Congressional Delegation), Washington, D.C., March 2013, April 2012, and May 2011.

Where do I go from Yale?” Career Mentoring Workshop.  Organizer, Chair, and Speaker, May 14, 2013.

Pharma/Biotech Boot Camp – Patent and Non-patent Exclusivity (presentation), C5 Conferences, San Francisco, CA, September 19, 2007.

Current Best Practices for Achieving Total Product Life Cycle Protection (presentation), C5 Conferences, London, U.K., April 19, 2005.

Getting an Extension on Your Pharmaceutical Patent (presentation), C5 Conferences, New York, NY, October 6, 2004 and January 28, 2004.

Eurolegal Conference:  Getting an Extension on Your Pharmaceutical Patent (presentation), C5 Conferences, London, U.K., July 5, 2004.

Pharmaceutical and Biotech Patent Due Diligence:  Assessing a Company’s Freedom to Operate (presentation), American Conference Institute, New York, NY, December 4, 2003.

Managing Biotech Patent Estates (presentation), MIT Enterprise Forum, New Haven, CT, October 8, 2003.

Maximizing Pharmaceutical Patent Life Cycles (presentation), American Conference Institute, New York, NY, April 2, 2003.

Sabatelli, A.D. The Hatch-Waxman Amendments: Understanding the Implications of Orange Book Listings and Paragraph IV Certifications (presentation and publication), Eighteenth Annual Joint Patent Seminar, New York, NY, May 2, 2002.

Sabatelli, A.D.  Impediments to Global Patent Law Harmonization, NKY Law Review, vol. 22, no. 3, pp. 579-620, 1995.

Anthony can be reached at


1994 Ohio; registered to practice before U.S. Patent and Trademark Office


1994 - Salmon P. Chase College of Law, JD cum laude
1984 - Yale University, Ph.D., Organic Chemistry
1979 - Fairfield University, BS, Chemistry summa cum laude